Storys aus Amsterdam,

Filtern
  • 25.04.2013 – 10:01

    UBM Live

    2 Weeks Left Until Food ingredients Istanbul!

    Amsterdam (ots/PRNewswire) - On 7-9 May 2013, Fi Istanbul will become the food ingredients powerhouse exhibition, joining together two of the largest economies, Europe and Asia, together with the Middle East and North Africa. Asia and Europe are amongst the largest economies in the world with Turkey bridging these advanced markets. With such a superb geographical location, a rapidly expanding economy and being one of the ...

  • 18.04.2013 – 12:58

    UBM Live

    CPhI South East Asia Indicates Rapid Pharma Sector Growth for the ASEAN

    Amsterdam (ots/PRNewswire) - Record numbers, a focus on development initiatives and analysis of the regional harmonisation programme helps stimulate increased partnerships CPhI, a division of UBM Live, announces that this year's recent CPhI South East Asia 2013, which ran from 20-22nd March at the Jakarta International Expo in Indonesia, was the most successful so far. ...

  • 12.04.2013 – 10:01

    UBM Live

    India: the Future of the Food Industry

    Amsterdam (ots/PRNewswire) - India is the new hotspot for sourcing food ingredients and Fi India is creating the driving change in one of the world's most successful economies. India is the 2nd largest population in the world, has the 3rd largest economy and ranks 2nd in the world in terms of agricultural production. It is no wonder that India is fast becoming an essential player in the global food ingredients market. AC ...

  • 15.03.2013 – 09:02

    UBM Live

    The Largest Ingredients Sourcing Hub in Latin America

    Amsterdam (ots/PRNewswire) - For the first time, food and pharmaceutical industries will join forces to create the largest ingredients event in Latin America The food and beverage industry is witnessing a move from reactive to proactive, with consumers now actively seeking functional foods that provide benefit-adding solutions to the various health challenges they currently face or will face later in life. Over the last ...

  • 18.12.2012 – 08:03

    Norgine

    Norgine and SpePharm Holding Enter Into Joint Venture

    Amsterdam (ots/PRNewswire) - Norgine BV (Amsterdam) and SpePharm Holding BV (Amsterdam) announced today that they have concluded a broad collaboration agreement under which the two companies have invested in a 50:50 joint venture, SpePharm AG, which has acquired the entire product portfolio of SpePharm Holding, including Savene(R), MuGard(R), Xerotin(R), PROther(R) and the Dantrium(R) brands. The new joint venture will ...

  • 17.12.2012 – 10:01

    Cognizant

    Cognizant Tops KPMG's Client Satisfaction Rankings Across Europe

    - Scores High on Key Performance Indicators London And Amsterdam (ots/PRNewswire) - Cognizant [http://www.cognizant.com/] announced today that it has topped the client satisfaction and relationship rankings in KPMG's Outsourcing 2012 study of service provider performance across Europe. Cognizant topped the rankings in general satisfaction and relationship ...

  • 13.12.2012 – 18:07

    Mitsubishi Chemical Advanced Materials AG

    Quadrant ruled to have been correctly acquired by Aquamit

    Amsterdam/Zurich (ots) - Swiss Takeover Board (TOB) confirms correctness of Quadrant offer price; Sarasin Investmentfonds AG (now part of the Safra Group) defeated in long-standing legal dispute The Swiss Takeover Board (TOB) issued a order today reaffirming the correctness of the public tender offer made by Aquamit B.V. for Quadrant AG in 2009. The TOB confirms in its order that the offer price paid to minority ...

  • 22.10.2012 – 16:31

    Shire Pharmaceuticals Group Plc

    International Study Reveals Disconnect Between Patients and Healthcare Professionals (HCPs) over Symptom Burden in Ulcerative Colitis (UC)

    Amsterdam (ots/PRNewswire) - The results of an international survey to assess patients' and healthcare professionals' (HCPs') differing perceptions of ulcerative colitis have been presented at a Shire organised press briefing during the 20th United European Gastroenterology Week (UEGW) meeting in Amsterdam today. ...

  • 25.07.2012 – 13:11

    Atradius N.V.

    Atradius Publishes Guide to Trading with India

    Amsterdam (ots/PRNewswire) - As part of its series of reports designed to help businesses to trade profitably with the world's emerging markets, global credit insurer Atradius has published 'Trade successfully with India'. The report lists ten principles that business should adhere to when seeking to make their mark in this vast and diverse market. Those principles include understanding the family oriented business ...

  • 03.04.2012 – 10:03

    Atradius N.V.

    Atradius Collections Increases Customer Satisfaction for Third Year in a Row

    Amsterdam (ots/PRNewswire) - ? Atradius Collections released the results of its recent customer satisfaction survey revealing outscoring the results of the previous three years. The survey is conducted annually and investigates customer views on Atradius Collections' performance in national and international debt collections. The overall survey satisfaction score of ...

  • 16.12.2011 – 14:23

    NTT Europe Ltd

    NTT Europe Expands Global IP Network With new PoP in EvoSwitch Datacentre, Amsterdam

    London and Amsterdam (ots/PRNewswire) - NTT Europe consolidates European footprint amid plans for eastern European expansion NTT Europe, a wholly owned subsidiary of NTT Communications Corporation [http://www.ntt.com/index-e.html ] (NTT Com), announced today that it has expanded the reach of the NTT Communications' Tier 1 Global IP Network in Europe with a new Point of ...

  • 24.10.2011 – 09:38

    Agendia B.V.

    Agendia Appoints New CEO and Supervisory Board Member

    Irvine, California and Amsterdam (ots/PRNewswire) - Agendia, an innovative molecular diagnostics company, today announced that its supervisory board of directors has appointed David Macdonald as chief executive officer. This follows the resignation of the company's co-founder and chief executive officer, Dr. Bernhard Sixt. Dr. Sixt will remain with the company in an advisory capacity. Agendia also announced the addition ...

  • 18.10.2011 – 15:03

    Agendia B.V.

    EORTC, BIG, and Agendia Announce Completion of Patient Recruitment for International MINDACT Study

    BRUSSELS, IRVINE, California, and AMSTERDAM, October 18, 2011 (ots/PRNewswire) -- The EORTC, BIG, and Agendia, a commercial-stage molecular cancer diagnostics company, today announced the completion of patient registration for the EORTC 10041/BIG3-04 MINDACT (Microarray In Node negative and 1-3 positive lymph node Disease may Avoid Chemotherapy Trial) study. More than ...

  • 06.10.2011 – 09:00

    Synova S.A.

    Synova S.A. attracts CHF 20m in growth capital from HPE

    Ecublens, Switzerland / Amsterdam, the Netherlands (ots) - Holland Private Equity ("HPE") invested substantial primary capital in Synova S.A. ("Synova") in a capital increase of up to CHF 20 million to become its largest outside shareholder. The expansion capital will allow Synova to further execute its internationalization, sales expansion and fuel further product development of its unique water-jet guided laser cutting ...

  • 03.10.2011 – 15:03

    Agendia B.V.

    Agendia Successfully Completes Bi-Annual FDA Inspection

    Irvine, California and Amsterdam (ots/PRNewswire) - Agendia, an innovative molecular cancer diagnostics company, today announced that the company successfully completed a recent, routine inspection of its Irvine, California-based laboratories by the US Food and Drug Administration (FDA). Agendia received FDA 510(k) clearance for its MammaPrint(R) breast cancer recurrence test in early 2007. It remains the first and only ...

  • 20.09.2011 – 11:02

    Layar

    Layar Enters in Partnership With Telefonica I+D for Visual Search Technology

    Amsterdam (ots/PRNewswire) - Layar, the largest open platform for mobile augmented reality (AR), today announced they entered into a strategic partnership with Telefonica I+D for providing them with their market leading Visual Search Technology: IRIS. Visual Search enables Layar to search through millions of images to identify these images and correctly augment them on ...

  • 19.09.2011 – 15:09

    Agendia B.V.

    Breast Cancer Research and Treatment Highlights Development and Validation of BluePrint®

    Irvine, California and Amsterdam (ots/PRNewswire) - - Peer-Reviewed Article Notes That Multi-Gene Subtyping Profile Provides Deeper Insight Into Breast Cancer Agendia, an innovative molecular cancer diagnostics company, today announced that a published report highlighting the development and validation of its 80-gene BluePrint breast cancer profile was published online ...